Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $250.7b | $162.67 | -0.6% | 12.5K |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $228.7b | $620.52 | +0.2% | 213 |
 DHR | Danaher Corporation | Precision Medicine Platforms | $147.6b | $203.22 | -0.2% | 230 |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $141.4b | $519.19 | 0.0% | 223 |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $86.8b | $787.83 | 0.0% | 20 |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $47.2b | $342.35 | 0.0% | 175 |
 WAT | Waters Corp | Precision Medicine Platforms | $40.6b | $408.86 | 0.0% | 1.0K |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $35.8b | $247.41 | 0.0% | 287 |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $32.2b | $202.68 | 0.0% | 139 |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $27.7b | $125.81 | 0.0% | 9 |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $26.9b | $314.63 | 0.0% | N/A |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $21.9b | $167.26 | 0.0% | 5 |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $15.0b | $72.25 | 0.0% | 105.2K |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $14.6b | $128.68 | 0.0% | 38 |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $13.0b | $66.45 | 0.0% | 20 |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $12.1b | $80.48 | 0.0% | 22 |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $11.7b | $60.93 | 0.0% | 29.8K |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $11.4b | $71.36 | 0.0% | 250 |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $10.9b | $344.54 | 0.0% | 10 |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $10.2b | $51.54 | 0.0% | 4.2K |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $9.9b | $332.27 | 0.0% | 1.3K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $9.9b | $114.25 | 0.0% | 3.8K |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $9.8b | $123.96 | 0.0% | N/A |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $9.1b | $42.09 | +0.5% | 2.2K |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $8.5b | $132.87 | 0.0% | 630 |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $8.2b | $69.13 | 0.0% | 1.4K |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $7.0b | $25.70 | 0.0% | 120 |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $6.6b | $100.25 | 0.0% | 163 |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $5.5b | $52.40 | 0.0% | 2.0K |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $4.7b | $18.53 | 0.0% | 805 |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $4.5b | $100.91 | 0.0% | 19 |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.49 | +0.0% | 3.5M |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $3.9b | $24.85 | 0.0% | N/A |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $3.9b | $38.04 | 0.0% | 177 |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $3.6b | $41.05 | 0.0% | 92 |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $3.1b | $45.51 | 0.0% | 542 |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $3.0b | $24.07 | 0.0% | 3.4K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Precision Medicine PlatformsGenetic Testing & Diagnostics | $2.6b | $88.48 | 0.0% | 311 |
 CDNA | CareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $2.6b | $52.35 | 0.0% | 45 |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $2.6b | $6.85 | 0.0% | 68 |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $2.4b | $20.71 | 0.0% | 165 |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $2.2b | $18.40 | 0.0% | 80 |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $2.1b | $39.77 | 0.0% | 4 |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.8b | $5.02 | 0.0% | 15 |
 PSNL | Personalis, Inc. Common Stock | Genetic Testing & Diagnostics | $1.8b | $16.36 | 0.0% | 70 |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $1.8b | $11.92 | 0.0% | 7.4K |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $1.8b | $35.54 | 0.0% | 211 |
 ANRO | Alto Neuroscience Inc. | Precision Medicine Platforms | $1.4b | $32.05 | 0.0% | N/A |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.4b | $24.66 | 0.0% | N/A |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $1.4b | $31.70 | 0.0% | 16.3K |